Keywords: ec, approves, novartis, galvus, europe, swiss, drug

EC approves Novartis' Galvus in Europe

Article | 08 October 2007

Swiss drug major Novartis says that its anti-diabetic Galvus (vidagliptin) has been approved by the European Commission. The dipeptidyl peptidase-4 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Nystatin

Go to drug listing